Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology
Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology
Recruiting · NCT06856525 · Registry updated 2026-03-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dissolved Phase HXe-129 MRI: A Novel Biomarker to Quantify Pulmonary Pathology | Electronic Cigarette Related Lung Damage | Recruiting | Phase 2 / Phase 3 | 2026-03-17 | NCT06856525 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Duke University | 446 |
| George Mason University | 19 |
| Y. Michael Shim, MD | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke University | Durham | United States | 91 |
| University of Virginia | Charlottesville | United States | 122 |